These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27571905)

  • 21. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
    PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
    Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
    Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.
    Hoft DF; Babusis E; Worku S; Spencer CT; Lottenbach K; Truscott SM; Abate G; Sakala IG; Edwards KM; Creech CB; Gerber MA; Bernstein DI; Newman F; Graham I; Anderson EL; Belshe RB
    J Infect Dis; 2011 Sep; 204(6):845-53. PubMed ID: 21846636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.
    Cowling BJ; Ng S; Ma ES; Fang VJ; So HC; Wai W; Cheng CK; Wong JY; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2012 Sep; 55(5):695-702. PubMed ID: 22670050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
    Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
    Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J; Arévalo MT; Chen Y; Chen S; Zeng M
    Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
    Carlock MA; Allen JD; Hanley HB; Ross TM
    PLoS One; 2024; 19(6):e0301157. PubMed ID: 38917104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
    Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
    mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season.
    Kim JH; Mishina M; Chung JR; Cole KS; Nowalk MP; Martin JM; Spencer S; Flannery B; Zimmerman RK; Sambhara S
    J Infect Dis; 2016 Oct; 214(7):1030-8. PubMed ID: 27534687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems biology of vaccination for seasonal influenza in humans.
    Nakaya HI; Wrammert J; Lee EK; Racioppi L; Marie-Kunze S; Haining WN; Means AR; Kasturi SP; Khan N; Li GM; McCausland M; Kanchan V; Kokko KE; Li S; Elbein R; Mehta AK; Aderem A; Subbarao K; Ahmed R; Pulendran B
    Nat Immunol; 2011 Jul; 12(8):786-95. PubMed ID: 21743478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
    PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.
    Madan RP; Tan M; Fernandez-Sesma A; Moran TM; Emre S; Campbell A; Herold BC
    Clin Infect Dis; 2008 Mar; 46(5):712-8. PubMed ID: 18230041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.
    van der Most RG; Clément F; Willekens J; Dewé W; Walravens K; Vaughn DW; Leroux-Roels G
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28446441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
    Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.